Cargando…
Successful Resection of Cisplatin-Resistant Renal Pelvic Cancer after the Administration of Pembrolizumab as Second-Line Therapy
Pembrolizumab has been used as a second-line systemic therapy for urothelial carcinoma. We herein report a case of cisplatin-resistant renal-pelvic urothelial carcinoma that was successfully resected after pembrolizumab treatment. A 74-year-old woman was referred to our hospital for further examinat...
Autores principales: | Kawahara, Takashi, Mochizuki, Taku, Sugimura, Rumiko, Izumi, Koji, Kuroda, Shinnosuke, Miyoshi, Yasuhide, Nakaigawa, Noboru, Yao, Masahiro, Tanabe, Mikiko, Uemura, Hiroji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6696768/ https://www.ncbi.nlm.nih.gov/pubmed/31427950 http://dx.doi.org/10.1159/000501715 |
Ejemplares similares
-
Long-Term Control of Metastatic Renal Cell Carcinoma Using Pazopanib
por: Kawahara, Takashi, et al.
Publicado: (2019) -
Clear cell adenocarcinoma of the prostatic urethra: A case report
por: Sugimura, Rumiko, et al.
Publicado: (2018) -
Fluorescent Light-Guided Cystoscopy with 5-ALA Aids in Accurate Surgical Margin Detection for TURBO: A Case Report
por: Takamoto, Daiji, et al.
Publicado: (2018) -
Paraganglioma in the bladder: a case report
por: Iwamoto, Genta, et al.
Publicado: (2017) -
A Case of Switching from GnRH Agonist to Antagonist for Castration Resistant Prostate Cancer Control
por: Sugimura, Rumiko, et al.
Publicado: (2019)